AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32410694 — intervention group
Group type: EXPERIMENTAL
Intervention: Atabecestat (various dosages)
Number of subjects: 114
Study 32410694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 35099555 — intervention group
Group type: EXPERIMENTAL
Intervention: Darvadstrocel
Number of subjects: 89
Study 35099555 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 89
Study 32852428 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm Pulsed Dye Laser treatment (fluence 7.5 J/cm2, 3-ms pulse duration, no dynamic cooling, 10-mm spot size, 10% overlap between pulses, 2 stacked pulses)
Number of subjects: 24
Study 32852428 — intervention group
Group type: COMPARATOR
Intervention: Sham/control treatment
Number of subjects: 24
Study 35815882 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-discharge mobile app
Number of subjects: 282
Study 35815882 — intervention group
Group type: COMPARATOR
Intervention: Usual postoperative care
Number of subjects: 282
Study 33820208 — intervention group
Group type: EXPERIMENTAL
Intervention: EGN model for predicting the impact of fiber nonlinearity on optical coherent transmission systems at zero or near-zero dispersion.
Number of subjects: 0
Study 33820208 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-form EGN-model approximation capable of handling high, low, and near-zero or zero dispersion fibers.
Number of subjects: 0
Study 35260948 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpipe with pictorial health warning label (PHWL)
Number of subjects: 60
Study 35260948 — intervention group
Group type: COMPARATOR
Intervention: Waterpipe with no pictorial health warning label (no-PHWL)
Number of subjects: 60
Study 34452786 — intervention group
Group type: EXPERIMENTAL
Intervention: Microosteoperforations (MOPs) procedure under local anesthesia using a Propel device
Number of subjects: 30
Study 34452786 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional treatment)
Number of subjects: 30
Study 33284337 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial toxicity (FT)
Number of subjects: 536
Study 33284337 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversations about costs
Number of subjects: 536
Study 33297830 — intervention group
Group type: EXPERIMENTAL
Intervention: OTC information only
Number of subjects: 778
Study 33297830 — intervention group
Group type: EXPERIMENTAL
Intervention: OTC information plus POP information
Number of subjects: 778
Study 32144909 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electrical acupoint stimulation (LEAS)
Number of subjects: 177
Study 32144909 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track surgery (FTS)
Number of subjects: 177
Study 32144909 — intervention group
Group type: EXPERIMENTAL
Intervention: FTS + LEAS
Number of subjects: 177
Study 32144909 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 177
Study 32144909 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAS
Number of subjects: 177
Study 32144909 — intervention group
Group type: EXPERIMENTAL
Intervention: FTS
Number of subjects: 177
Study 34813821 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-guided training (HRV-G)
Number of subjects: 12
Study 34813821 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (TRAD-G)
Number of subjects: 12
Study 33511688 — intervention group
Group type: EXPERIMENTAL
Intervention: Staphylococcus hominis applied on half-side of cheek for eight times in 1 month
Number of subjects: 293
Study 33511688 — intervention group
Group type: COMPARATOR
Intervention: Placebo side
Number of subjects: 293
Study 32559817 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment (immune or targeted therapy)
Number of subjects: 2536
Study 32559817 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOG PS ≥2 with symptomatic brain metastases
Number of subjects: 2536
Study 32559817 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOG PS ≥2 without symptomatic brain metastases
Number of subjects: 2536
Study 32559817 — intervention group
Group type: EXPERIMENTAL
Intervention: LDH >500 U/L
Number of subjects: 2536
Study 35674759 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsules containing multi-strain at least 1.6×10^9 CFU/g bacteria
Number of subjects: 46
Study 32665035 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 300 mg
Number of subjects: 1500
Study 32665035 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) (low or moderate dose)
Number of subjects: 1500
Study 32665035 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ASA and UFH
Number of subjects: 1500
Study 32665035 — intervention group
Group type: COMPARATOR
Intervention: Neither ASA nor UFH
Number of subjects: 1500
Study 35140061 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based education programme for salt reduction
Number of subjects: 592
Study 35140061 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 592
Study 34111130 — intervention group
Group type: EXPERIMENTAL
Intervention: iStent inject trabecular bypass stent (TBS) + cataract surgery (Cat Sx)
Number of subjects: 0
Study 34111130 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery (Cat Sx) alone
Number of subjects: 0
Study 33587543 — intervention group
Group type: EXPERIMENTAL
Intervention: EXOGEN Ultrasound Bone Healing System
Number of subjects: 0
Study 33587543 — intervention group
Group type: COMPARATOR
Intervention: Standard fracture care
Number of subjects: 0
Study 32218747 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Psychoeducation Group (MBPEG) program
Number of subjects: 124
Study 33988772 — intervention group
Group type: EXPERIMENTAL
Intervention: CU‐CNPs
Number of subjects: 50
Study 33988772 — intervention group
Group type: EXPERIMENTAL
Intervention: CNPs
Number of subjects: 50
Study 33988772 — intervention group
Group type: EXPERIMENTAL
Intervention: %6 NaOCl
Number of subjects: 50
Study 33988772 — intervention group
Group type: EXPERIMENTAL
Intervention: %6 NaOCl+%9 editronate (HEBP)
Number of subjects: 50
Study 33988772 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (Control)
Number of subjects: 50
Study 32674675 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg (R10)
Number of subjects: 105
Study 32674675 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg (R15)
Number of subjects: 105
Study 32674675 — intervention group
Group type: COMPARATOR
Intervention: DAPT (aspirin 75 mg and clopidogrel 75 mg)
Number of subjects: 105
Study 32674675 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg (R10) and Rivaroxaban 15 mg (R15)
Number of subjects: 105
Study 36462524 — intervention group
Group type: EXPERIMENTAL
Intervention: N lactamica (105 CFU in 1 mL PBS)
Number of subjects: 31
Study 36462524 — intervention group
Group type: COMPARATOR
Intervention: PBS (1 mL PBS)
Number of subjects: 31
Study 33047696 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase-contrast video microscopy method in addition to conventional method
Number of subjects: 53
Study 33047696 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 53
Study 35150215 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquablation
Number of subjects: 181
Study 35150215 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 181
Study 34183490 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 4317
Study 34183490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4317
Study 33316604 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over left lateral PFC
Number of subjects: 121
Study 33316604 — intervention group
Group type: COMPARATOR
Intervention: Control tDCS over temporoparietal cortex
Number of subjects: 121
Study 33316604 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 121
Study 32716349 — intervention group
Group type: EXPERIMENTAL
Intervention: Five commercial EV isolation kits
Number of subjects: 3
Study 32716349 — intervention group
Group type: COMPARATOR
Intervention: Ultracentrifugation (UC)
Number of subjects: 3
Study 32038628 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute dynamic exercise
Number of subjects: 0
Study 32038628 — intervention group
Group type: COMPARATOR
Intervention: Nadolol (β1 + β2‐AR antagonist)
Number of subjects: 0
Study 32038628 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol (β1‐AR antagonist)
Number of subjects: 0
Study 34548531 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate for six weeks
Number of subjects: 0
Study 34548531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33207825 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel method for automatic detection of red lesions (RLs) using proprietary database
Number of subjects: 564
Study 33207825 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel method for automatic detection of red lesions (RLs) using public database
Number of subjects: 564
Study 33207825 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel method for automatic detection of exudates (EXs) using proprietary database
Number of subjects: 564
Study 33207825 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel method for automatic detection of exudates (EXs) using public database
Number of subjects: 564
Study 34148509 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching of ankle plantar flexors for 5 minutes
Number of subjects: 26
Study 34148509 — intervention group
Group type: COMPARATOR
Intervention: Control condition (standing for 6 minutes)
Number of subjects: 26
Study 33720367 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvesting
Number of subjects: 0
Study 33720367 — intervention group
Group type: COMPARATOR
Intervention: Open vein harvesting
Number of subjects: 0
Study 32610465 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus Casei Shirota strain 3 × 10^10 CFU)
Number of subjects: 20
Study 32610465 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 20
Study 35676543 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional training
Number of subjects: 66
Study 35676543 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic training
Number of subjects: 66
Study 35676543 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training
Number of subjects: 66
Study 34887657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) treatment
Number of subjects: 70
Study 34887657 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 70
Study 34887657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) treatment (in adherent patients)
Number of subjects: 70
Study 34887657 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control) (in adherent patients)
Number of subjects: 70
Study 33165116 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline hydrochloride
Number of subjects: 0
Study 35420272 — intervention group
Group type: EXPERIMENTAL
Intervention: LLR algorithm-based model
Number of subjects: 100
Study 35420272 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiomics features with clinical features
Number of subjects: 100
Study 35420272 — intervention group
Group type: EXPERIMENTAL
Intervention: SVM classifier with radial kernel function
Number of subjects: 100
Study 32991794 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 μg mRNA-1273 vaccine
Number of subjects: 40
Study 32991794 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μg mRNA-1273 vaccine
Number of subjects: 40
Study 32991794 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine (both doses)
Number of subjects: 40
Study 32991794 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine
Number of subjects: 40
Study 36088426 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete macroscopic en bloc resection with adjacent structures
Number of subjects: 0
Study 36088426 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiotherapy
Number of subjects: 0
Study 36088426 — intervention group
Group type: EXPERIMENTAL
Intervention: Histology-tailored chemotherapy regimen
Number of subjects: 0
Study 36088426 — intervention group
Group type: COMPARATOR
Intervention: Observational studies
Number of subjects: 0
Study 35427481 — intervention group
Group type: EXPERIMENTAL
Intervention: EV71vac (aluminium phosphate‐adjuvanted inactivated EV71 vaccine), administered as two doses via intramuscular injection 56 days apart, with a third booster dose for children aged 2-23 months on day 366.
Number of subjects: 3061
Study 35427481 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered as two doses via intramuscular injection 56 days apart.
Number of subjects: 3061
Study 35427481 — intervention group
Group type: EXPERIMENTAL
Intervention: EV71vac (aluminium phosphate‐adjuvanted inactivated EV71 vaccine)
Number of subjects: 3061
Study 34578925 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet intervention
Number of subjects: 79
Study 34578925 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary intervention)
Number of subjects: 79
Study 33057823 — intervention group
Group type: EXPERIMENTAL
Intervention: Single application of Olanedine
Number of subjects: 393
Study 33057823 — intervention group
Group type: EXPERIMENTAL
Intervention: Double application of Olanedine
Number of subjects: 393
Study 33057823 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 393
Study 34581220 — intervention group
Group type: EXPERIMENTAL
Intervention: Slowed down rehabilitation
Number of subjects: 60
Study 34581220 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 60
Study 33928516 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulatory consciousness training (32 individual sessions over 8 weeks)
Number of subjects: 11
Study 33928516 — intervention group
Group type: COMPARATOR
Intervention: Control condition (baseline tests)
Number of subjects: 11
Study 33933433 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-Hz rTMS on individualized inferior parietal lobule (IPL) targets
Number of subjects: 0
Study 33933433 — intervention group
Group type: COMPARATOR
Intervention: rTMS of the pre-supplementary motor area (preSMA)
Number of subjects: 0
Study 33933433 — intervention group
Group type: COMPARATOR
Intervention: Stroop task
Number of subjects: 0
Study 32115719 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-1 genotypic characteristics and transmitted drug resistance surveillance
Number of subjects: 224
Study 34718635 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g, 200 g, 300 g whole beetroot (BR)
Number of subjects: 24
Study 34718635 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 g whole beetroot (BR)
Number of subjects: 24
Study 34718635 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 g whole beetroot (BR)
Number of subjects: 24
Study 34718635 — intervention group
Group type: COMPARATOR
Intervention: Potassium nitrate (1000 mg)
Number of subjects: 24
Study 33981951 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity greater than 9 MET hours per week
Number of subjects: 799
Study 33981951 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity 0-9 MET hours per week
Number of subjects: 799
Study 32867508 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 14005
Study 36469317 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient decision aid targeted to age and sex
Number of subjects: 424
Study 33781913 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAd63-KH vaccine (1 × 10^10 viral particles for adults, 7.5 × 10^10 viral particles for adults and adolescents)
Number of subjects: 24
Study 33781913 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAd63-KH vaccine
Number of subjects: 24
Study 33781913 — intervention group
Group type: COMPARATOR
Intervention: AmBisome
Number of subjects: 24
Study 36409754 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV recency assay and viral load quantification using Asanté HIV‐1 Rapid Recency Assay and Roche Cobas System
Number of subjects: 184
Study 32806711 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of Leucine-Enriched Essential Amino Acids (LEAA)
Number of subjects: 20
Study 32806711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34228018 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visits postdischarge
Number of subjects: 0
Study 34228018 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term focused feedback
Number of subjects: 0
Study 35178112 — intervention group
Group type: EXPERIMENTAL
Intervention: Multitasking Test (MTT)
Number of subjects: 105
Study 35178112 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Visual Information Processing (RVP)
Number of subjects: 105
Study 35178112 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired Associates Learning (PAL)
Number of subjects: 105
Study 35178112 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MTT and RVP
Number of subjects: 105
Study 35178112 — intervention group
Group type: EXPERIMENTAL
Intervention: Education added to models
Number of subjects: 105
Study 33350698 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0
Study 33350698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32312284 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34152055 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasimelteon 20 mg
Number of subjects: 48
Study 34152055 — intervention group
Group type: COMPARATOR
Intervention: Zopiclone 7.5 mg
Number of subjects: 48
Study 34152055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32790196 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose teriparatide (40 μg)
Number of subjects: 69
Study 32790196 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose teriparatide (20 μg)
Number of subjects: 69
Study 32790196 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 69
Study 36323490 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 10 mg two times per day
Number of subjects: 4362
Study 36323490 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib 5 mg two times per day
Number of subjects: 4362
Study 36323490 — intervention group
Group type: COMPARATOR
Intervention: TNFi
Number of subjects: 4362
Study 36323490 — intervention group
Group type: COMPARATOR
Intervention: D-dimer
Number of subjects: 4362
Study 33826563 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) at a new dosing regimen (10 mg/kg load, 5 mg/kg/h infusion)
Number of subjects: 90
Study 33826563 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 90
Study 33826563 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 90
Study 33003132 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath MAC (McG)
Number of subjects: 50
Study 33003132 — intervention group
Group type: EXPERIMENTAL
Intervention: Storz C‐MAC PM (ST)
Number of subjects: 50
Study 33003132 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 50
Study 32271182 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 60
Study 32271182 — intervention group
Group type: COMPARATOR
Intervention: Femoral Triangle Block (FTB)
Number of subjects: 60
Study 36881400 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigator Reports (IR)
Number of subjects: 841
Study 36881400 — intervention group
Group type: COMPARATOR
Intervention: Clinical Events Committee (CEC)
Number of subjects: 841
Study 32748570 — intervention group
Group type: EXPERIMENTAL
Intervention: Lafenta transdermal fentanyl patch (11.0 mg)
Number of subjects: 2
Study 36400984 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV with active humidification
Number of subjects: 182
Study 36400984 — intervention group
Group type: COMPARATOR
Intervention: HFNC
Number of subjects: 182
Study 33225426 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-expanded stents (≥90%)
Number of subjects: 151
Study 33225426 — intervention group
Group type: COMPARATOR
Intervention: Under-expanded stents (<90%)
Number of subjects: 151
Study 35756957 — intervention group
Group type: EXPERIMENTAL
Intervention: Neem chip (10% absorbable)
Number of subjects: 14
Study 35756957 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue diode laser
Number of subjects: 14
Study 35756957 — intervention group
Group type: COMPARATOR
Intervention: Phase I therapy alone
Number of subjects: 14
Study 34619639 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuminuria
Number of subjects: 480698
Study 34333190 — intervention group
Group type: EXPERIMENTAL
Intervention: Japanese cedar pollen sublingual immunotherapy (SLIT) tablets (5000 Japanese Allergy Units)
Number of subjects: 1042
Study 34333190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1042
Study 36114800 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-aid (DA)
Number of subjects: 0
Study 36114800 — intervention group
Group type: COMPARATOR
Intervention: Informative brochure
Number of subjects: 0
Study 33285016 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful awareness component
Number of subjects: 256
Study 33285016 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress tolerance component
Number of subjects: 256
Study 33285016 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion modulation component
Number of subjects: 256
Study 33285016 — intervention group
Group type: EXPERIMENTAL
Intervention: Values-based decision making component
Number of subjects: 256
Study 36345029 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulation experimental teaching model
Number of subjects: 199
Study 36345029 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching mode
Number of subjects: 199
Study 35969429 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education through CKD awareness campaign and mobile health technologies
Number of subjects: 126
Study 35969429 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 126
Study 32078947 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright posture
Number of subjects: 54
Study 32078947 — intervention group
Group type: COMPARATOR
Intervention: Stooped posture
Number of subjects: 54